ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

Clinical Trials Approved By NCI

November 26, 2010

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

Komen Foundation Announces Second Grant Cycle For 1995

April 28, 1995

Conte Institute Leafs Scientific Effort On Central Europe Environmental Clean-Up

March 19, 1993